Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk

• Ganna Chornokur,

  Affiliation Division of Population Sciences, Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, United States of America

  ⨯
• Hui-Yi Lin,

  Affiliation Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida, United States of America

  ⨯
• Jonathan P. Tyrer,

  Affiliation Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK

  ⨯
• Kate Lawrenson,

  Affiliation Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, United States of America

  ⨯
• Joe Dennis,

  Affiliation Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK

  ⨯
• Ernest K. Amankwah,

  Affiliations Division of Population Sciences, Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, United States of America, Clinical and Translational Research Organization, All Children’s Hospital Johns Hopkins Medicine, St Petersburg, Florida, United States of America

  ⨯
• Xiaotao Qu,

  Affiliation Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida, United States of America

  ⨯
• Ya-Yu Tsai,

  Affiliation Division of Population Sciences, Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, United States of America

  ⨯
• Heather S. L. Jim,

  Affiliation Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida, United States of America

  ⨯
• Zhihua Chen,

  Affiliation Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida, United States of America

  ⨯
• Ann Y. Chen,

  Affiliation Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida, United States of America

  ⨯
• Jennifer Permuth-Wey,

  Affiliation Division of Population Sciences, Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, United States of America

  ⨯
• Katja KH. Aben,

  Affiliations Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands, Comprehensive Cancer Center The Netherlands, Nijmegen, The Netherlands

  ⨯
• Hoda Anton-Culver,

  Affiliation Genetic Epidemiology Research Institute, Center for Cancer Genetics Research and Prevention, University of California Irvine, Irvine, California, United States of America

  ⨯
• Natalia Antonenkova,

  Affiliation N.N. Alexandrov National Cancer Centre of Belarus, Minsk, Belarus

  ⨯
• Fiona Bruinsma,

  Affiliation Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia

  ⨯
• Elisa V. Bandera,

  Affiliation Cancer Prevention and Control Program, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States of America

  ⨯
• Yukie T. Bean,

  Affiliations Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, Oregon, United States of America, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, United States of America

  ⨯
• Matthias W. Beckmann,

  Affiliation Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-University, Erlangen-Nuremberg Comprehensive Cancer Center, Erlangen EMN, Erlangen, Germany

  ⨯
• Maria Bisogna,

  Affiliation Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Line Bjorge,

  Affiliations Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway, Centre for Cancer Biomarkers, Department of Clinical Medicine, University of Bergen, Bergen, Norway

  ⨯
• Natalia Bogdanova,

  Affiliation Radiation Oncology Research Unit, Hannover Medical School, Hannover, Germany

  ⨯
• Louise A. Brinton,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Angela Brooks-Wilson,

  Affiliations Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, Canada, Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, Canada

  ⨯
• Clareann H. Bunker,

  Affiliation Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania, United States of America

  ⨯
• Ralf Butzow,

  Affiliations Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, HUS, Finland, Department of Pathology, Helsinki University Central Hospital, Helsinki, Finland

  ⨯
• Ian G. Campbell,

  Affiliations Cancer Genetics Laboratory Research Division, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Australia, Department of Pathology, the University of Melbourne, Parkville, Australia, Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia

  ⨯
• Karen Carty,

  Affiliations Department of Gynaecological Oncology, Glasgow Royal Infirmary, Glasgow, United Kingdom, The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom

  ⨯
• Jenny Chang-Claude,

  Affiliation German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany

  ⨯
• Linda S. Cook,

  Affiliation Division of Epidemiology and Biostatistics, Department of Internal Medicine, University of New Mexico, Albuquerque, New Mexico, United States of America

  ⨯
• Daniel W. Cramer,

  Affiliation Obstetrics and Gynecology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Julie M. Cunningham,

  Affiliation Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Cezary Cybulski,

  Affiliation International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland

  ⨯
• Agnieszka Dansonka-Mieszkowska,

  Affiliation Department of Pathology, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland

  ⨯
• Andreas du Bois,

  Affiliations Department of Gynaecology and Gynaecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/ Knappschaft GmbH, Essen, Germany, Department of Gynaecology and Gynaecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany

  ⨯
• Evelyn Despierre,

  Affiliation Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology and Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium

  ⨯
• Ed Dicks,

  Affiliation Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK

  ⨯
• Jennifer A. Doherty,

  Affiliations Department of Epidemiology, The Geisel School of Medicine Hanover, New Hampshire, United States of America, Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington, United States of America

  ⨯
• Thilo Dörk,

  Affiliation Gynaecology Research Unit, Hannover Medical School, Hannover, Germany

  ⨯
• Matthias Dürst,

  Affiliation Department of Gynecology, Jena University Hospital, Friedrich Schiller University, Jena, Germany

  ⨯
• Douglas F. Easton,

  Affiliations Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom, Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, United States of America

  ⨯
• Diana M. Eccles,

  Affiliation Faculty of Medicine, University of Southampton, Southampton, United Kingdom

  ⨯
• Robert P. Edwards,

  Affiliation Ovarian Cancer Center of Excellence, Womens Cancer Research Program, Magee-Womens Research Institute and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States of America

  ⨯
• Arif B. Ekici,

  Affiliation Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany

  ⨯
• Peter A. Fasching,

  Affiliations Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-University, Erlangen-Nuremberg Comprehensive Cancer Center, Erlangen EMN, Erlangen, Germany, University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, Los Angeles, California, United States of America

  ⨯
• Brooke L. Fridley,

  Affiliation Biostatistics and Informatics Shared Resource, University of Kansas Medical Center, Kansas City, Kansas, United States of America

  ⨯
• Yu-Tang Gao,

  Affiliation Department of Epidemiology, Shanghai Cancer Institute, Shanghai, China

  ⨯
• Aleksandra Gentry-Maharaj,

  Affiliation Women's Cancer, Institute for Women's Health, University College London, London, United Kingdom

  ⨯
• Graham G. Giles,

  Affiliations Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia, Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Australia

  ⨯
• Rosalind Glasspool,

  Affiliation The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom

  ⨯
• Marc T. Goodman,

  Affiliations Cancer Prevention and Control, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America, Community and Population Health Research Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, United States of America

  ⨯
• Jacek Gronwald,

  Affiliation International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland

  ⨯
• Patricia Harrington,

  Affiliation Department of Oncology, The Centre for Cancer Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom

  ⨯
• Philipp Harter,

  Affiliations Department of Gynaecology and Gynaecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/ Knappschaft GmbH, Essen, Germany, Department of Gynaecology and Gynaecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany

  ⨯
• Alexander Hein,

  Affiliation Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-University, Erlangen-Nuremberg Comprehensive Cancer Center, Erlangen EMN, Erlangen, Germany

  ⨯
• Florian Heitz,

  Affiliations Department of Gynaecology and Gynaecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/ Knappschaft GmbH, Essen, Germany, Department of Gynaecology and Gynaecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany

  ⨯
• Michelle A. T. Hildebrandt,

  Affiliation Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Peter Hillemanns,

  Affiliation Gynaecology Research Unit, Hannover Medical School, Hannover, Germany

  ⨯
• Claus K. Hogdall,

  Affiliation The Juliane Marie Centre, Department of Gynecology, Righospitalet, University of Copenhagen, Copenhagen, Denmark

  ⨯
• Estrid Hogdall,

  Affiliations Molecular Unit, Department of Pathology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark, Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark

  ⨯
• Satoyo Hosono,

  Affiliation Department of Preventive Medicine, Kyushu University Faculty of Medical Science, Nagoya, Aichi, Japan

  ⨯
• Anna Jakubowska,

  Affiliation International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland

  ⨯
• Allan Jensen,

  Affiliation Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark

  ⨯
• Bu-Tian Ji,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Beth Y. Karlan,

  Affiliation Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America

  ⨯
• Linda E. Kelemen,

  Affiliation Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, United States of America

  ⨯
• Mellissa Kellar,

  Affiliations Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, Oregon, United States of America, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, United States of America

  ⨯
• Lambertus A. Kiemeney,

  Affiliation Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands

  ⨯
• Camilla Krakstad,

  Affiliations Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway, Centre for Cancer Biomarkers, Department of Clinical Medicine, University of Bergen, Bergen, Norway

  ⨯
• Susanne K. Kjaer,

  Affiliations Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark, Department of Gynaecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

  ⨯
• Jolanta Kupryjanczyk,

  Affiliation Department of Pathology, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland

  ⨯
• Diether Lambrechts,

  Affiliations Vesalius Research Center, VIB, Leuven, Belgium, Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Belgium

  ⨯
• Sandrina Lambrechts,

  Affiliation Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology and Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium

  ⨯
• Nhu D. Le,

  Affiliation Cancer Control Research, BC Cancer Agency, Vancouver, Canada

  ⨯
• Alice W. Lee,

  Affiliation Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, United States of America

  ⨯
• Shashi Lele,

  Affiliation Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, United States of America

  ⨯
• Arto Leminen,

  Affiliation Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, HUS, Finland

  ⨯
• Jenny Lester,

  Affiliation Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America

  ⨯
• Douglas A. Levine,

  Affiliation Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Dong Liang,

  Affiliation College of Pharmacy and Health Sciences, Texas Southern University, Houston, Texas, United States of America

  ⨯
• Boon Kiong Lim,

  Affiliation Department of Obstetrics and Gynaecology, University Malaya Medical Centre, University Malaya, Kuala Lumpur, Malaysia

  ⨯
• Jolanta Lissowska,

  Affiliation Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland

  ⨯
• Karen Lu,

  Affiliation Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Jan Lubinski,

  Affiliation International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland

  ⨯
• Lene Lundvall,

  Affiliation The Juliane Marie Centre, Department of Gynecology, Righospitalet, University of Copenhagen, Copenhagen, Denmark

  ⨯
• Leon F. A. G. Massuger,

  Affiliation Department of Gynaecology, Radboud University Medical Center, Nijmegen, The Netherlands

  ⨯
• Keitaro Matsuo,

  Affiliation Department of Preventive Medicine, Kyushu University Faculty of Medical Science, Nagoya, Aichi, Japan

  ⨯
• Valerie McGuire,

  Affiliation Department of Health Research and Policy—Epidemiology, Stanford University School of Medicine, Stanford, California, United States of America

  ⨯
• John R. McLaughlin,

  Affiliation Public Health Ontario, Toronto, Canada

  ⨯
• Iain McNeish,

  Affiliation Institute of Cancer Sciences, University of Glasgow, Wolfson Wohl Cancer research Centre, Beatson Institute for Cancer Research, Glasgow, UK

  ⨯
• Usha Menon,

  Affiliation Women's Cancer, Institute for Women's Health, University College London, London, United Kingdom

  ⨯
• Roger L. Milne,

  Affiliation Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia

  ⨯
• Francesmary Modugno,

  Affiliations Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania, United States of America, Women's Cancer Research Program, Magee-Women's Research Institute and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States of America, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America

  ⨯
• Kirsten B. Moysich,

  Affiliation Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, United States of America

  ⨯
• Roberta B. Ness,

  Affiliation The University of Texas School of Public Health, Houston, Texas, United States of America

  ⨯
• Heli Nevanlinna,

  Affiliation Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, HUS, Finland

  ⨯
• Ursula Eilber,

  Affiliation German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany

  ⨯
• Kunle Odunsi,

  Affiliation Department of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, New York, United States of America

  ⨯
• Sara H. Olson,

  Affiliation Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Irene Orlow,

  Affiliation Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Sandra Orsulic,

  Affiliation Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America

  ⨯
• Rachel Palmieri Weber,

  Affiliation Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• James Paul,

  Affiliation The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom

  ⨯
• Celeste L. Pearce,

  Affiliations Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, United States of America, Department of Epidemiology, University of Michigan School of Public Health,Ann Arbor, Michigan, United States of America

  ⨯
• Tanja Pejovic,

  Affiliations Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, Oregon, United States of America, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, United States of America

  ⨯
• Liisa M. Pelttari,

  Affiliation Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, HUS, Finland

  ⨯
• Malcolm C. Pike,

  Affiliations Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, United States of America, Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Elizabeth M. Poole,

  Affiliations Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America, Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America

  ⨯
• Harvey A. Risch,

  Affiliation Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut, United States of America

  ⨯
• Barry Rosen,

  Affiliation Department of Gynecology-Oncology, Princess Margaret Hospital, and Department of Obstetrics and Gynecology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada

  ⨯
• Mary Anne Rossing,

  Affiliation Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington, United States of America

  ⨯
• Joseph H. Rothstein,

  Affiliation Department of Health Research and Policy- Epidemiology, Stanford University School of Medicine, Stanford, California, United States of America

  ⨯
• Anja Rudolph,

  Affiliation German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany

  ⨯
• Ingo B. Runnebaum,

  Affiliation Department of Gynecology, Jena University Hospital, Friedrich Schiller University, Jena, Germany

  ⨯
• Iwona K. Rzepecka,

  Affiliation Department of Pathology, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland

  ⨯
• Helga B. Salvesen,

  Affiliations Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway, Centre for Cancer Biomarkers, Department of Clinical Medicine, University of Bergen, Bergen, Norway

  ⨯
• Eva Schernhammer,

  Affiliations Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America, Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America

  ⨯
• Ira Schwaab,

  Affiliation Institut für Humangenetik, Wiesbaden, Germany

  ⨯
• Xiao-Ou Shu,

  Affiliation Epidemiology Center and Vanderbilt, Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America

  ⨯
• Yurii B. Shvetsov,

  Affiliation Cancer Epidemiology Program, University of Hawaii Cancer Center, Hawaii, United States of America

  ⨯
• Nadeem Siddiqui,

  Affiliation Department of Gynaecological Oncology, Glasgow Royal Infirmary, Glasgow, United Kingdom

  ⨯
• Weiva Sieh,

  Affiliation Department of Health Research and Policy- Epidemiology, Stanford University School of Medicine, Stanford, California, United States of America

  ⨯
• Honglin Song,

  Affiliation Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK

  ⨯
• Melissa C. Southey,

  Affiliation Department of Pathology, the University of Melbourne, Parkville, Australia

  ⨯
• Beata Spiewankiewicz,

  Affiliation Department of Gynecologic Oncology, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland

  ⨯
• Lara Sucheston,

  Affiliation Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, United States of America

  ⨯
• Soo-Hwang Teo,

  Affiliations Cancer Research Initiatives Foundation, Sime Darby Medical Center, Subang Jaya, Malaysia, University Malaya Cancer Research Institute, University Malaya Medical Centre, University Malaya, Kuala Lumpur, Maylaysia

  ⨯
• Kathryn L. Terry,

  Affiliation Obstetrics and Gynecology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Pamela J. Thompson,

  Affiliations Cancer Prevention and Control, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America, Community and Population Health Research Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, United States of America

  ⨯
• Lotte Thomsen,

  Affiliation Department of Pathology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

  ⨯
• Ingvild L. Tangen,

  Affiliations Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway, Centre for Cancer Biomarkers, Department of Clinical Medicine, University of Bergen, Bergen, Norway

  ⨯
• Shelley S. Tworoger,

  Affiliations Obstetrics and Gynecology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America, Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America

  ⨯
• Anne M. van Altena,

  Affiliation Department of Gynaecology, Radboud University Medical Center, Nijmegen, The Netherlands

  ⨯
• Robert A. Vierkant,

  Affiliation Department of Health Science Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Ignace Vergote,

  Affiliation Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology and Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium

  ⨯
• Christine S. Walsh,

  Affiliation Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America

  ⨯
• Shan Wang-Gohrke,

  Affiliation German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany

  ⨯
• Nicolas Wentzensen,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Alice S. Whittemore,

  Affiliation Department of Health Research and Policy- Epidemiology, Stanford University School of Medicine, Stanford, California, United States of America

  ⨯
• Kristine G. Wicklund,

  Affiliation Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington, United States of America

  ⨯
• Lynne R. Wilkens,

  Affiliation Cancer Epidemiology Program, University of Hawaii Cancer Center, Hawaii, United States of America

  ⨯
• Anna H. Wu,

  Affiliation Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, United States of America

  ⨯
• Xifeng Wu,

  Affiliation Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Yin-Ling Woo,

  Affiliation Department of Obstetrics and Gynaecology, University Malaya Medical Centre, University Malaya, Kuala Lumpur, Malaysia

  ⨯
• Hannah Yang,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Wei Zheng,

  Affiliation Vanderbilt Epidemiology Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America

  ⨯
• Argyrios Ziogas,

  Affiliation Genetic Epidemiology Research Institute, Center for Cancer Genetics Research and Prevention, University of California Irvine, Irvine, California, United States of America

  ⨯
• Hanis N. Hasmad,

  Affiliation Cancer Research Initiatives Foundation, Sime Darby Medical Center, Subang Jaya, Malaysia

  ⨯
• Andrew Berchuck,

  Affiliation Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Georgia Chenevix-Trench on behalf of the AOCS management group,

  Affiliations QIMR Berghofer Medical Research Institute, Brisbane, Australia, Peter MacCallum Cancer Centre, East Melbourne, Australia

  ⨯
• Edwin S. Iversen,

  Affiliation Department of Statistics, Duke University, Durham, North Carolina, United States of America

  ⨯
• Joellen M. Schildkraut,

  Affiliation Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina, United States of America

  ⨯
• Susan J. Ramus,

  Affiliation Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, United States of America

  ⨯
• Ellen L. Goode,

  Affiliation Department of Health Science Research, Division of Epidemiology, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Alvaro N. A. Monteiro,

  Affiliation Division of Population Sciences, Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, United States of America

  ⨯
• Simon A. Gayther,

  Affiliation Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, United States of America

  ⨯
• Steven A. Narod,

  Affiliation Women's College Research Institute, University of Toronto, Toronto, Ontario, Canada

  ⨯
• Paul D. P. Pharoah,

  Affiliations Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Thomas A. Sellers,

  Affiliation Division of Population Sciences, Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, United States of America

  ⨯
•  [ ... ],
• Catherine M. Phelan

  * E-mail: catherine.phelan@moffitt.org

  Affiliation Division of Population Sciences, Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, United States of America

  ⨯
• [ view all ]
• [ view less ]